Acne fulminans (AF) is a severe and rare form of acne that can come with systemic symptoms and is hard to treat.
A case study discusses a 12-year-old boy who developed isotretinoin-induced AF (IIAF) and did not respond to standard treatments like oral steroids and isotretinoin.
The boy was successfully treated with adalimumab, suggesting it could be an effective off-label treatment option for resistant cases of IIAF in children.